The U.S. Food and Drug Administration and the Centers for Medicare & Medicaid Services have launched a parallel review pilot program that allows medical devices to be reviewed for approval by the FDA ...
Off-patent medicines provide people with access to high-quality essential treatment options that can be significantly less expensive than branded on-patent medicines. Off-patent therapies — generics ...
The FDA and Centers for Medicare & Medicaid Services have launched a parallel review pilot program for medical devices. The pilot will allow for the streamlined, concurrent review of devices by both ...
Genesee & Wyoming Inc. (G&W) subsidiaries Georgia Central Railway, L.P. (GC) and Heart of Georgia Railroad, Inc. (HOG) on Aug. 10 filed a petition with the Federal Railroad Administration (FRA) to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results